Clementia Pharmaceuticals Inc (CMTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2016 | 03-2016 | 12-2015 | |
| Operating Expenses | 4,144 | 4,703 | 0 |
| Operating Income | -4,144 | -4,703 | N/A |
| Interest Expense | -2,626 | 1,432 | 0 |
| Other Income | 112 | 103 | 0 |
| Pre-tax Income | -1,407 | -6,031 | 0 |
| Income Tax | 41 | 33 | N/A |
| Net Income Continuous | -1,447 | -6,064 | N/A |
| Net Income | $-1,447 | $-6,064 | $N/A |
| EPS Basic Total Ops | -0.62 | -2.58 | N/A |
| EPS Basic Continuous Ops | -0.62 | -2.58 | N/A |
| EPS Diluted Total Ops | -0.62 | -2.58 | N/A |
| EPS Diluted Continuous Ops | -0.62 | -2.58 | N/A |
| EBITDA(a) | $-4,101 | $-4,660 | $N/A |